L. Pearce Collins

A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

N. Barnes, Ian Pavord, John I. Bell et al. · Clinical & Experimental Allergy · 2011 · 216 citations

Anti‐eosinophil activity and clinical efficacy of the <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459 in eosinophilic esophagitis

Alex Straumann, Susanne Radonjic‐Hoesli, Ch. Bussmann et al. · Allergy · 2013 · 205 citations

Heightened response of eosinophilic asthmatic patients to the <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459

Roy Pettipher, Michael Hunter, Christopher Perkins et al. · Allergy · 2014 · 133 citations

Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459

Paul Cadden, Michael Hunter, L. Pearce Collins et al. · European Respiratory Journal · 2012 · 103 citations · Full text

The <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Allergy · 2012 · 84 citations